Gershenson DM - Search Results

1

Low-grade serous ovarian cancer: State of the science.

Slomovitz B, Gourley C, Carey MS, Malpica A, Shih IM, Huntsman D, Fader AN, Grisham RN, Schlumbrecht M, Sun CC, Ludemann J, Cooney GA, Coleman R, Sood AK, Mahdi H, Wong KK, Covens A, O'Malley DM, Lecuru F, Cobb LP, Caputo TA, May T, Huang M, Siemon J, Fernández ML, Ray-Coquard I, Gershenson DM. Slomovitz B, et al. Among authors: gershenson dm. Gynecol Oncol. 2020 Mar;156(3):715-725. doi: 10.1016/j.ygyno.2019.12.033. Epub 2020 Jan 20. Gynecol Oncol. 2020. PMID: 31969252 Review.

2

The effect of prolonged cisplatin-based chemotherapy on progression-free survival in patients with optimal epithelial ovarian cancer: "maintenance" therapy reconsidered.

Gershenson DM, Mitchell MF, Atkinson N, Silva EG, Kavanagh JJ, Morris M, Burke TW, Warner D, Wharton JT. Gershenson DM, et al. Gynecol Oncol. 1992 Oct;47(1):7-13. doi: 10.1016/0090-8258(92)90067-s. Gynecol Oncol. 1992. PMID: 1427404 Clinical Trial.

3

Choroidal metastasis from primary ovarian carcinoma.

Grendys EC, Tang RA, Gershenson DM. Grendys EC, et al. Among authors: gershenson dm. Gynecol Oncol. 1992 Aug;46(2):251-4. doi: 10.1016/0090-8258(92)90266-l. Gynecol Oncol. 1992. PMID: 1500031 No abstract available.

4

Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC).

Levenback C, Burke TW, Silva E, Morris M, Gershenson DM, Kavanagh JJ, Wharton JT. Levenback C, et al. Among authors: gershenson dm. Gynecol Oncol. 1992 Sep;46(3):317-21. doi: 10.1016/0090-8258(92)90224-7. Gynecol Oncol. 1992. PMID: 1526508

5

Minimally invasive vulvar carcinoma: an indication for conservative surgical therapy.

Kelley JL 3rd, Burke TW, Tornos C, Morris M, Gershenson DM, Silva EG, Wharton JT. Kelley JL 3rd, et al. Among authors: gershenson dm. Gynecol Oncol. 1992 Mar;44(3):240-4. doi: 10.1016/0090-8258(92)90050-s. Gynecol Oncol. 1992. PMID: 1541436

6

Superficially invasive squamous cell carcinoma of the cervix.

Copeland LJ, Silva EG, Gershenson DM, Morris M, Young DC, Wharton JT. Copeland LJ, et al. Among authors: gershenson dm. Gynecol Oncol. 1992 Jun;45(3):307-12. doi: 10.1016/0090-8258(92)90310-f. Gynecol Oncol. 1992. PMID: 1612508

7

Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer.

Jacob JH, Gershenson DM, Morris M, Copeland LJ, Burke TW, Wharton JT. Jacob JH, et al. Among authors: gershenson dm. Gynecol Oncol. 1991 Aug;42(2):146-50. doi: 10.1016/0090-8258(91)90335-3. Gynecol Oncol. 1991. PMID: 1894174

8

Five-year survival in patients given intra-arterial chemotherapy prior to radiotherapy for advanced squamous carcinoma of the cervix and vagina.

Patton TJ Jr, Kavanagh JJ, Delclos L, Wallace S, Haynie TP, Gershenson DM, Wharton JT, Bass S. Patton TJ Jr, et al. Among authors: gershenson dm. Gynecol Oncol. 1991 Jul;42(1):54-9. doi: 10.1016/0090-8258(91)90230-3. Gynecol Oncol. 1991. PMID: 1916511

9

Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide.

Burke TW, Stringer CA, Morris M, Freedman RS, Gershenson DM, Kavanagh JJ, Edwards CL. Burke TW, et al. Among authors: gershenson dm. Gynecol Oncol. 1991 Mar;40(3):264-7. doi: 10.1016/0090-8258(90)90289-w. Gynecol Oncol. 1991. PMID: 2013451 Clinical Trial.

10

Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC) for early-stage high-risk endometrial cancer: a preliminary analysis.

Stringer CA, Gershenson DM, Burke TW, Edwards CL, Gordon AN, Wharton JT. Stringer CA, et al. Among authors: gershenson dm. Gynecol Oncol. 1990 Sep;38(3):305-8. doi: 10.1016/0090-8258(90)90063-q. Gynecol Oncol. 1990. PMID: 2227540

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

509 results

Search Page